Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Boston Scientific Corp BSX

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The Company's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.


NYSE:BSX - Post by User

Post by edwardebreen15on Aug 19, 2022 1:57am
201 Views
Post# 34906579

Defibrillators Market Trends, Demand, Share & Size 2022-27

Defibrillators Market Trends, Demand, Share & Size 2022-27

According to IMARC Group’s latest report, titled Defibrillators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global defibrillators market reached a value of US$ 4.7 Billion in 2021. Defibrillators are extensively used to deliver a therapeutic shock to the patient’s heart in severe cases of life-threatening conditions, such as pulseless ventricular tachycardia, cardiac arrhythmia, and ventricular fibrillation. The electric shock from the medical device depolarizes the heart muscles and restores its normal electric pulse. Manual/wearable defibrillators, automated external defibrillators (AED), transvenous or subcutaneous implantable cardioverter defibrillators, and implantable cardioverter defibrillators are most commonly available in the market.

 

Request for a PDF sample of this report: https://www.imarcgroup.com/defibrillators-market/requestsample

 

The rapidly rising prevalence of sudden cardiac arrest (SCA) and cardiovascular diseases across the globe is a key factor driving the defibrillators market growth. Additionally, the increasing geriatric population and shifting focus toward public access defibrillators (PAD) by the private and public organizations are contributing to the market growth. The initiatives undertaken by the government of various countries to increase awareness and promote training regarding defibrillators are acting as another growth-inducing factor. Other factors, such as the development of wearable cardioverter defibrillators (WCDs) and the rising government and private investments in the healthcare industry across the globe, are creating a positive outlook for the market. Looking forward, IMARC Group expects the defibrillators market to reach US$ 7.0 Billion by 2027, exhibiting a CAGR of 6.86% during 2022-2027.

 

Checkout Now: https://www.imarcgroup.com/checkout?id=2184&method=1

 

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

 

Competitive Landscape with Key Players:

  • Asahi Kasei Zoll Medical Corporation
  • Biotronik
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic Inc.
  • Nihon Kohden Corporation
  • Schiller AG
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Stryker Corporation

Market Segmentation:

 

Breakup by Product Type:

  • Implantable Defibrillators
    • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
    • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
    • Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
  • External Defibrillators
    • Manual External Defibrillator
    • Automated External Defibrillator (AEDs)
    • Wearable Cardioverter Defibrillator (WCDs) 

Breakup by End-User:

  • Hospitals and Clinics
  • Prehospital Care Settings
  • Cardiac Centers
  • Homecare Settings
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Ask Analyst for Customization and Explore full report with TOC & List of Figureshttps://www.imarcgroup.com/defibrillators-market

 

Key highlights of the report:                                                    

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 

Related Reports by IMARC Group:

Minimally Invasive Surgery Market: https://www.imarcgroup.com/minimally-invasive-surgery-market

Dental Implants Market: https://www.imarcgroup.com/dental-implants-market

Healthcare It Market: https://www.imarcgroup.com/healthcare-it-market

Blood Pressure Monitoring Devices Market: https://www.imarcgroup.com/blood-pressure-monitoring-devices-market

Home Fitness Equipment Market: https://www.imarcgroup.com/home-fitness-equipment-market

 

 

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

 

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800

<< Previous
Bullboard Posts
Next >>